<DOC>
	<DOCNO>NCT00676195</DOCNO>
	<brief_summary>The purpose study test tolerability efficacy N-Acetyl Cysteine ( NAC ) child Autism .</brief_summary>
	<brief_title>An Open-Label Study N-Acetyl Cysteine Children With Autism</brief_title>
	<detailed_description>N-Acetyl Cysteine ( NAC ) compound increase level Glutathione , body 's main antioxidant . Glutathione compound blood part natural defense system ( antioxidant system ) . Anti-oxidants protect body damage cause internal toxin call free radical . It possible child Autism tend low level glutathione , important compound body help combat effect toxic free radical . We hope study antioxidant system detail , increase understanding reason people develop Autism design well way treat individual condition . This study mean test safety tolerability N-Acetyl Cysteine effectiveness treatment behavioral difficulty child autism . It also examine possible benefit agent improve core deficit autism social deficit .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Subjects eligible study participate Doubleblind , randomize , placebo control study NAcetyl Cysteine Autism study Stanford University meet follow criterion : 1 . Outpatients 3.0 12.11 year age inclusive 2 . Males female physically healthy 3. diagnosis autism base Diagnostic Statistical Manual ( DSMIVTR ) criterion , Autism Diagnostic InterviewRevised , expert clinical evaluation 4 . Clinical Global Impression Severity rating 4 5 . Care provider reliably bring subject clinic visit , provide trustworthy rating , interacts subject regular basis 6 . Ability subject swallow compound 7 . Stable concomitant medication least 2 week 8 . No planned change psychosocial intervention openlabel NAcetyl Cysteine trial 1 . Diagnostic Statistical Manual ( DSMIVTR ) diagnosis schizophrenia , schizoaffective disorder , psychotic disorder , otherwise specify 2 . Active medical problem : unstable seizure , significant physical illness ( e.g. , serious liver renal pathology ) 3 . Pregnancy sexually active female 4 . Subjects take antioxidant agent glutathione prodrugs exclude study except compound least 4 week</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>N-Acetyl Cysteine</keyword>
</DOC>